HealthStream Defines a New Enterprise Category Alongside the EHR and ERP, the Enterprise Clinical Workforce Platform (ECWP)

NASHVILLE, Tenn., September 14, 2026--HealthStream (Nasdaq: HSTM), a leading healthcare technology platform company for clinical workforce solutions, today defined the Enterprise Clinical Workforce Platform (ECWP), establishing a new enterprise category for healthcare built on a single, verified record for every clinician. For decades, health systems have standardized on two enterprise systems: the electronic health record (EHR) for the clinical record and enterprise resource planning (ERP) for

HealthCap Invests in AMRA Medical to Accelerate Global Growth in Quantitative MRI

LINKÖPING, Sweden, September 14, 2026--HealthCap Invests in AMRA Medical to meet global demand for precise, scalable advanced muscle and fat imaging in clinical research and healthcare.

Eyes On Eyecare Names Matt Keating Chief Financial Officer

Veteran eyecare media finance executive joins the C-suite as the company continues its growth trajectory SAN DIEGO, Sept. 14, 2026 /PRNewswire-PRWeb/ -- Eyes On Eyecare (Eyes On), the #1 provider of clinical and career education for optometrists and ophthalmologists, today announced that...

Dr. Thomas Pane Obtains Hospital Privileges at Holy Cross in Fort Lauderdale ...

(PR-inside.com) Double board-certified plastic surgeon adds a hospital-based surgical option for patients whose medical circumstances call for one. PALM BEACH GARDENS, FL / ACCESS Newswire / September 14, 2026 / Dr. Thomas Pane , a double board-certified plastic surgeon practicing in Palm Beach Gardens, has obtained hospital privileges at Holy Cross in Fort Lauderdale. The privileges allow him to perform procedures in a hospital setting when a patient's individual circumstances or medical needs make a hospital more appropriate than an office-based surgical facility or an ambulatory surgery center. The privileges add to the settings already available to Dr. Pane. He performs procedures at ..

Care Transformation Studio and ISfTeH Partner to Expand Global Access to Digital Health Expertise

Care Transformation Studio today announced a strategic partnership with the Switzerland-based International Society for Telemedicine and eHealth (ISfTeH). This collaboration will provide healthcare organizations, government agencies, and funding institutions with streamlined access to...

Dr. Thomas Pane Obtains Hospital Privileges at Holy Cross in Fort Lauderdale

Double board-certified plastic surgeon adds a hospital-based surgical option for patients whose medical circumstances call for one.

Glo Welcomes Award-Winning Women's Health Expert Dr. Desi Bartlett to Launch New Perimenopause and Midlife Programming

The 2025 IDEA Fitness Leader of the Year and MSN's #1 Top Health Voice of 2026 joins Glo as its September Featured Guest Teacher HONOLULU, Sept. 14, 2026 /PRNewswire/ -- Dr. Desi Bartlett, Ed.D., founder of The BodyMind Workout™, today announced a new partnership with Glo, the premier...

Davos Healthcare™ Launches Global AI-Powered Hospital Evaluations at C3 New York Summit

Ambassador Deborah Birx Announces New Data-Driven Framework Evaluating 16,239 Hospitals Across 65 Countries NEW YORK, Sept. 14, 2026 /PRNewswire/ -- At today's 15TH annual C3 US NYC Davos of Healthcare™ Summit, held alongside the United Nations General Assembly, Davos Healthcare™...

VEW Media Marks 25 Years of Building Visibility for Companies Across Industries and Around the World

Working With Clients From All Walks of Life, From Fortune 500 Companies to Respected Experts and Global Brands, VEW Media Has Spent 25 Years Finding and Telling Stories That Matter NORTH ATTLEBORO, MA - September 14, 2026 ( NEWMEDIAWIRE ) - VEW Media, the PR agency that has been helping clients get ViEWed globally since 2001, is celebrating its 25 year of business. Over the past quarter-century, VEW Media has represented an extraordinarily diverse roster of clients, including consumer brands, authors, physicians, technology innovators, and Fortune 500 companies, helping each turn what makes them distinctive into stories that resonate with national, international, and industry media. It is celebrating its 25th anniversary in September 2026. Since opening in 2001, the agency has helped compa

GeoVax and CEPI Enter Agreement to Utilize CEPI Centralised Laboratory Network to Support GEO-MVA Phase 3 Trial

Independent Evaluation Supports GEO-MVA Pivotal Phase 3 Program Advances GeoVax’s Strategy to Expand and Diversify MVA Vaccine Supply ATLANTA, GA - September 14, 2026 ( NEWMEDIAWIRE ) - GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing vaccines and immunotherapies against high consequence infectious diseases and solid tumor cancers, today announced that it has entered into a Memorandum of Agreement with the Coalition for Epidemic Preparedness Innovations (CEPI) providing GeoVax access to clinical trial sample testing services through the CEPI Centralised Laboratory Network in support of its planned pivotal GEO-MVA Phase 3 immune-bridging study. The agreement represents an important step in the continued development of GEO-MVA, GeoVax’s MVA-based vaccine ca

Ensysce Biosciences' Professor Richard Langford Selected to Speak at ...

(PR-inside.com) SAN DIEGO, CA / ACCESS Newswire / September 14, 2026 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company") a clinical-stage biotechnology company developing novel neuroplastogenic therapies beyond mood disorders, with an initial focus on CRPS (Complex Regional Pain Syndrome), today announced that Richard Langford, Chief Medical Officer of Cy Biopharma, has been selected to present in person at the U.S. Food and Drug Administration's ("FDA") public hearing, "Considerations for Potential Future Therapeutic Use of Psychedelic Drugs," being held today, Monday, September 14, 2026 at the FDA's White Oak Campus in Silver Spring, Maryland. Dr. Langford is among a limited group ..

Ensysce Biosciences' Professor Richard Langford Selected to Speak at FDA Public Hearing on the Potential Future Therapeutic Use of Psychedelic Drugs